Education
About Us
Working with TipRanks
Follow Us
Brainsway (IL:BWAY)
:BWAY
BWAY Stock Chart & Stats
2459.00
0.01(0.06%)
At close: 4:00 PM EST
2459.00
0.01(0.06%)
Day’s Range― - ―
52-Week Range1,444.00 - 2,940.00
Previous CloseN/A
Volume32.24K
Average Volume (3M)85.46K
Market Cap
972.73M
Enterprise Value749.92M
Total Cash (Recent Filing)70.46M
Total Debt (Recent Filing)6.75M
Price to Earnings (P/E)43.1
Beta0.07
Next Earnings
Mar 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.80
Shares Outstanding39,128,260
10 Day Avg. Volume88,081
30 Day Avg. Volume85,462
Financial Highlights & Ratios
PEG Ratio-0.33
Price to Book (P/B)2.56
Price to Sales (P/S)3.88
P/FCF Ratio24.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Brainsway News
BWAY FAQ
What was Brainsway’s price range in the past 12 months?
Brainsway lowest stock price was 1444.00 and its highest was 2940.00 in the past 12 months.
What is Brainsway’s market cap?
Brainsway’s market cap is 972.73M.
When is Brainsway’s upcoming earnings report date?
Brainsway’s upcoming earnings report date is Mar 11, 2026 which is in 104 days.
How were Brainsway’s earnings last quarter?
Brainsway released its earnings results on Nov 11, 2025. The company reported 13.8 earnings per share for the quarter, beating the consensus estimate of N/A by 13.8.
Is Brainsway overvalued?
According to Wall Street analysts Brainsway’s price is currently Overvalued.
Does Brainsway pay dividends?
Brainsway does not currently pay dividends.
What is Brainsway’s EPS estimate?
Brainsway’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway have?
Brainsway has 39,128,260 shares outstanding.
What happened to Brainsway’s price movement after its last earnings report?
Brainsway reported an EPS of 13.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.238%.
Which hedge fund is a major shareholder of Brainsway?
Currently, no hedge funds are holding shares in IL:BWAY
Company Description
Brainsway
Brainsway (BWAY) is a medical technology company that specializes in the development and commercialization of non-invasive therapies for mental health disorders, primarily focusing on major depressive disorder and other neurological conditions. The company’s flagship product is its Deep Transcranial Magnetic Stimulation (dTMS) system, which utilizes advanced electromagnetic technology to stimulate specific areas of the brain. Brainsway operates in the healthcare sector, providing innovative treatment options that are alternatives to traditional pharmacological therapies.
BWAY Company Deck
BWAY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in revenue and system shipments, successful strategic investments, and improved financial guidance. However, there were increased operating expenses and delays in FDA clearance for a strategic partner's product. Overall, the positives significantly outweigh the negatives.View all IL:BWAY earnings summaries